Skip to main content
SpringerLink
Log in

Familiäres Mammakarzinom — Beratung und Betreuung betroffener Familien

  • Chapter
Management des MAMMAKARZINOMS

Part of the book series: Onkologie ((ONKAKTUELL))

  • 75 Accesses

Zusammenfassung

Das Mammakarzinom ist die häufigste Krebserkrankung der Frau in den westlichen Ländern, die Inzidenz steigend. Die kumulative Wahrscheinlichkeit bis zum 80. Lebensjahr an einem Mammakarzinom zu erkranken, wird für eine Frau in Deutschland auf über 7 % geschätzt (Chang-Claude et al. 1995). Die überwiegende Zahl tritt sporadisch, d. h. ohne familiäre Häufung, auf.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Literatur

  • Ambrosone CB, Freudenheim JL, Graham S et al. (1995) Cytochrome P4501A1 and glutathione S-transferase (M1), genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res 55:3483–3485

    PubMed  CAS  Google Scholar 

  • Athma P, Rappaport R, Swift M (1996) Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92:130–134

    Article  PubMed  CAS  Google Scholar 

  • Beral V, Hermon C, Kay C (1999) Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of general practitioner’s contraception study. BMJ 318:96–100

    Article  PubMed  CAS  Google Scholar 

  • Berchuck A, Schildkraut JM, Markus JR, Futrael PA (199) Managing hereditary ovarian cancer risk. Cancer 86 (11 Suppl):2517–2524

    Google Scholar 

  • Bergh J, Norberg T, Sjogren S, Lindgren A, Holmberg L (1995) Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med 1:1029–1034

    Article  PubMed  CAS  Google Scholar 

  • Chang-Claude J, Becker H, Caligo M et al. (199) Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration projekt on familial breast cancer. Dis Markers 15:53–65

    Google Scholar 

  • Chang-Claude J, Becher H, Hamann U, Schroeder-Kurth T (1995) Risikoabschätzung für das familiäre Auftreten von Brustkrebs. Zentralbl Gynäkol 117: 423–434

    PubMed  CAS  Google Scholar 

  • Claus EB, Risch NJ, Thompson WD (1991) Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 48: 232–242

    PubMed  CAS  Google Scholar 

  • Claus EB, Risch NJ, Thompson WD (1994) Autosomal-dominant inheritance of early onset breast cancer. Cancer 73: 643–651

    Article  PubMed  CAS  Google Scholar 

  • Claus EB, Schildkraut JM, Thompson WD, Risch NJ (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77: 2318–2324

    Article  PubMed  CAS  Google Scholar 

  • CRC (Cancer Research Campaign) (1999) Cancer risks in BRCA 1 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst 91:1310–1316

    Article  Google Scholar 

  • Easton D, Ford D, Peto J (1993) Inherited susceptibility to breast cancer. Cancer Surv 18:95–113

    PubMed  CAS  Google Scholar 

  • Eisen A, Weber BL (199) Prophylactic mastectomy — The price of fear. N Engl J Med 340:137–138

    Google Scholar 

  • Fisher B, Constantino I, Wickerham DL et al. (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. Journal of the National Cancer Institute 90 (18): 1371–1388

    Article  PubMed  CAS  Google Scholar 

  • FitzGerald MG, Bean JM, Hedge SR et al. (1997) Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet 15:307–310

    Article  CAS  Google Scholar 

  • Foulkes WD, Wong N, Brunei JS et al. (1997) Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer. Clin Cancer Res 3:2465–2469

    PubMed  CAS  Google Scholar 

  • Frebourg T, Barbier N, Yan YX et al. (1995) Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet 56: 608–615

    PubMed  CAS  Google Scholar 

  • Gayther SA, Warren W, Mazoyer S et al (1995) Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nature Genet. 11: 428–433

    Article  PubMed  CAS  Google Scholar 

  • Gayther SA, Mangion J, Russell P et al. (1997) Variation of risks of breast and ovarian cancer associated with different germ-line mutations of the BRCA2 gene. Nature Genet. 15:103–105

    Article  PubMed  CAS  Google Scholar 

  • Hartmann LC, Schaid DJ, Woods JE et al. (1999) Efficiacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340: 77–84

    Article  PubMed  CAS  Google Scholar 

  • Hartmann LC, Schaid DJ, McDonnel SK et al. (2000) Contralateral prophylactic mastectomy (CMP) in women with a personal and family history of breast cancer (BC). ASCO-Mee-ting 2000

    Google Scholar 

  • Hartmann LC, Schaid D, Sellers T et al. (2000) Bilateral prophylactic mastectomy (PM) in BRCA1/2 mutation carriers. Proc Am Assoc cancer Res 41: 222. abstract

    Google Scholar 

  • Miki Y et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCAi. Science 266: 66–71

    Article  PubMed  CAS  Google Scholar 

  • Mohammed SN, Smith P, Hodgson SV et al. (1998) Family history and survivak ub premenopausal breast cancer. Br J Cancer 77: 2252–2256

    Article  PubMed  CAS  Google Scholar 

  • Narod SA, Risch H, Moslehi R et al. (1998) Oral contraceptives and the risk of hereditary ovarian cancer. N Engl J Med 339: 424–428

    Article  PubMed  CAS  Google Scholar 

  • Peto J, Collins N, Barfoot R et al. (1999) Prevalence of BRCA2 gene mutations in patients with early-stage breast cancer. J Natl Cancer Inst 91:943–949

    Article  PubMed  CAS  Google Scholar 

  • Philipps KA, Andrulis IL, Goodwin PJ (1999) Breast carcinomas arising in carriers of mutations in BRCAi or BRCA2: are they prognostically different ? J Clin Oncol 17:3653–3663

    Google Scholar 

  • Powles T, Eeles R, Ashley S et al. (1998) Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital cg-hemoprevention trial. Lancet 352: 98–101

    PubMed  CAS  Google Scholar 

  • Potter CE, Beldock JG, Rosenthal G, Osborne MP (1995) A clinician-friendly computer program for calculating breast cancer risk using the Gail and Claus models. Ann NY Acad Sci 768:301–307

    Article  PubMed  CAS  Google Scholar 

  • Rebbeck TR, Levin AM, Eisen A et al. (1999) Breast cancer risk after bilateral Prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 91:1475–1479

    Article  PubMed  CAS  Google Scholar 

  • Runnebaum IB, Nagarajan M, Bowman M, Soto D, Sukumar S (1991) Mutations in p53 as potential molecular markers for human breast cancer. Proc Natl Acad Sci USA 88:10657–10661

    Article  PubMed  CAS  Google Scholar 

  • Runnebaum IB, Tong XW, König R et al. (1995) p53-based blood test for P53PIN3 and risk for sporadic ovarian cancer. Lancet 345: 994

    Article  PubMed  CAS  Google Scholar 

  • Rebbeck TR, Levin AM, Eisen A et al. (1999) Breast cancer risk after bilateral Prophylactic oophorectomy in BRCAi mutation carriers. J Natl Cancer Inst 91:1475–1479

    Article  PubMed  CAS  Google Scholar 

  • Schmidt S, Becher H, Chang-Claude J (1998) Breast cancer risk assessment: use of complete pedigree information and the effect of misspecified ages at diagnosis oif affected relatives. Hum Genet 102:348–356

    Article  PubMed  CAS  Google Scholar 

  • Shattuck-Eidens D, McClure M, Simard J et al. (1995) A collaborative survey of 80 mutations in the BRCAi breast and ovarian cancer susceptibility gene. Implications for presymp-tomatic testing and screening. Jama 273:535–541

    Article  PubMed  CAS  Google Scholar 

  • Tavtigian SV, Simard J, Rommens J et al. (1996) The complete BRCA2 gene and mutations in chromosome i3q-linked kindreds. Nat Genet 12:333–337

    Article  PubMed  CAS  Google Scholar 

  • Teng DH, Bogden R, Mitchell J et al. (1996) Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nat Genet 13: 241–244

    Article  PubMed  CAS  Google Scholar 

  • Verhoog LC, Brekelmans CTM, Seynaeve C et al. (1998) Survival and tumor characteristics of breast cancer patients with germline mutations of BRCAi. Lancet 351:316–321

    Article  PubMed  CAS  Google Scholar 

  • Veronesi U, Maisonneuve P, Costa A et al. (1998) Prevention of breast cancer with tamoxifen: prelimary findings from the Italian randomized trial among hysterectomized women. Lancet 352: 93–97

    PubMed  CAS  Google Scholar 

  • Volm T, Herröder N, Hundenborn S et al. (2000) Estimating the prior probability of carrying a BRCA-1 or -2 mutation using anamnestic criteria. ASCO Meeting 2000

    Google Scholar 

  • Wooster R, Bignell G, Lancaster J et al. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789–792

    Article  PubMed  CAS  Google Scholar 

  • Wooster R, Ford D, Mangion J, Ponder BA, Peto J, Easton DF, Stratton MR (1993) Absence of linkage to the ataxia telangiectasia locus in familial breast cancer. Hum Genet 92:91–94

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. I. B. Runnebaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Emmerich
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitätsfrauenklinik, Universität Ulm, Prittwitzstraße 43, D-89075, Ulm, Deutschland

    Rolf Kreienberg  & Tanja Volm  & 

  2. Städt. Kliniken Frankfurt-Höchst Akademisches Lehrkrankenhaus, Universität Frankfurt, Frauenklinik, Gotenstraße 6-8, D-65929, Frankfurt, Deutschland

    Volker Möbus

  3. Untere Kippstraße 21, D-69198, Schriesheim, Deutschland

    Dieter Alt

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Runnebaum, I.B., Emmerich, D. (2002). Familiäres Mammakarzinom — Beratung und Betreuung betroffener Familien. In: Kreienberg, R., Volm, T., Möbus, V., Alt, D. (eds) Management des MAMMAKARZINOMS. Onkologie Aktuell . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-08460-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-08460-1_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-08461-8

  • Online ISBN: 978-3-662-08460-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation